Pilonidal Sinus
Conditions
Keywords
Pilonidal sinus, Crystallized phenol, Limberg Flap, Modified Limberg Flap, Karydakis, Recurrence, Complications, Recovery duration, Time to return to work
Brief summary
Although surgical techniques such as limberg flap. modified limberg flap and karydakis are currently most popular treatment methods for pilonidal disease, crystallized phenol application is also successfully used for pilonidal sinus treatment by different centers. We believe crystallized phenol application could become a good alternative to popular surgical interventions using transposition flaps.
Detailed description
Pilonidal sinus disease (PSD) is usually located at sacrococcygeal region of the body and mostly effect young males causing loss of labor and school time. Its incidence is reported 26 per 100000 in a Norwegian study. Although there are many treatment modalities either surgical or conservative, ideal treatment is still a matter of debate. Surgical techniques such as limberg flap, modified limberg flap and karydakis are most popular treatment methods for pilonidal disease crystallized phenol application is also successfully used for pilonidal sinus treatment by different centers. We would like to compare flap techniques and crystallized phenol application for complications, recurrence, patient comfort, duration of recovery and return to work. We believe crystallized phenol application could become a good alternative to popular surgical interventions using transposition flaps.
Interventions
Crystallized phenol application for pilonidal disease treatment. After sacrococcygeal region of the patient is cleaned from hairs, hairs inside the sinus are removed than crystallized phenol is applied in to the cleaned sinus. Following 2 minutes of phenol exposure, crystallized phenol is removed from the sinus. Crystallized phenol application will be repeated weekly for 4 weeks.
PROCEDURELimberg Flap
Limberg Flap surgery for pilonidal disease treatment
PROCEDUREModified Limberg Flap
Limberg flap surgery rhomboid incision is made asymmetrically 2-3 cm lateral to the midline on the side opposite to the donor area.
PROCEDUREKarydakis Flap
Karydakis Flap surgery for pilonidal disease treatment
Sponsors
S.B. Konya Education and Research Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Patients with pilonidal disease
Exclusion criteria
* Previous history of pilonidal disease treatment * Pregnant or breast-feeding women * Systemic diseases that would affect wound healing * Diabetes * Chronic renal failure * Autoimmune diseases * Malignant diseases
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of recurrence | 3rd year | Patients will be followed up for recurrence for three years. Total recurrence will be evaluated at the end of 3rd year. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of patient comfort | 1st year | Patients will be queried for patient comfort at the end of first year |
| Assessment of recovery duration | 3rd month | Post procedure wound recovery duration will be recorded |
| Assessment of complications | 3rd month | Patients will be followed up for procedure related complications. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Assessment of time before patient returns to work/routine physical activity | 3rd month | Patients will be queried for when they felt comfortable to return to work and/or their routine physical activity. |
Countries
Turkey (Türkiye)
Outcome results
None listed